We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$20.9B
AUM Growth
+$1.18B
Cap. Flow
-$95.1M
Cap. Flow %
-0.46%
Top 10 Hldgs %
24.18%
Holding
1,443
New
92
Increased
575
Reduced
559
Closed
58

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$49.3M
2
IQV icon
IQVIA
IQV
+$42.7M
3
IJR icon
iShares Core S&P Small-Cap ETF
IJR
+$34.7M
4
COR icon
Cencora
COR
+$32.7M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$22.7M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$61.8M
2
PGR icon
Progressive
PGR
+$60.9M
3
ANET icon
Arista Networks
ANET
+$23.1M
4
PATH icon
UiPath
PATH
+$22.5M
5
EBAY icon
eBay
EBAY
+$22.2M

Sector Composition

Rank Sector Weight
1 Technology 23.2%
2 Healthcare 11.29%
3 Financials 10.11%
4 Consumer Discretionary 8.76%
5 Industrials 6.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DVY icon
126
iShares Select Dividend ETF
DVY
$23.8B
$33.6M 0.16%
248,395
+8,983
+4% +$1.16M
RPM icon
127
RPM International
RPM
$13.8B
$33.5M 0.16%
276,636
+28,728
+12% +$3.33M
PAYX icon
128
Paychex
PAYX
$41.1B
$33.5M 0.16%
249,325
-19,210
-7% -$2.44M
APD icon
129
Air Products & Chemicals
APD
$65.2B
$33.4M 0.16%
112,279
-4,412
-4% -$1.21M
DTE icon
130
DTE Energy
DTE
$30.6B
$32.4M 0.15%
252,071
-2,758
-1% -$333K
CNX icon
131
CNX Resources
CNX
$4.77B
$32.2M 0.15%
989,666
-13,607
-1% -$366K
ICE icon
132
Intercontinental Exchange
ICE
$84.1B
$32.1M 0.15%
199,661
-137,685
-41% -$21.2M
VO icon
133
Vanguard Mid-Cap ETF
VO
$107B
$31.6M 0.15%
478,768
+3,624
+0.8% +$228K
PFE icon
134
Pfizer
PFE
$141B
$30.9M 0.15%
1,067,929
-28,214
-3% -$823K
KVUE icon
135
Kenvue
KVUE
$37.4B
$30.8M 0.15%
1,331,422
-136,897
-9% -$2.84M
LRCX icon
136
Lam Research
LRCX
$365B
$30.1M 0.14%
368,440
-18,540
-5% -$1.61M
TGT icon
137
Target
TGT
$63.7B
$29.5M 0.14%
189,524
-668
-0.4% -$99.5K
USB icon
138
US Bancorp
USB
$98.9B
$29.5M 0.14%
645,308
-28,695
-4% -$1.26M
CDW icon
139
CDW
CDW
$17.6B
$29.4M 0.14%
130,043
-42
-0% -$9.32K
SMAR
140
DELISTED
Smartsheet Inc.
SMAR
$29.4M 0.14%
531,557
+437,371
+464% +$21.2M
TEL icon
141
TE Connectivity
TEL
$60.2B
$29.3M 0.14%
194,264
+23,755
+14% +$3.56M
PM icon
142
Philip Morris
PM
$305B
$29.1M 0.14%
239,459
+14,719
+7% +$1.71M
ZTS icon
143
Zoetis
ZTS
$32.2B
$29M 0.14%
148,287
+260
+0.2% +$47.9K
WFC icon
144
Wells Fargo
WFC
$264B
$28.9M 0.14%
511,710
-54,331
-10% -$3.07M
BDX icon
145
Becton Dickinson
BDX
$43.8B
$28.9M 0.14%
119,811
+12,048
+11% +$2.82M
ETN icon
146
Eaton
ETN
$155B
$28.7M 0.14%
86,571
+328
+0.4% +$100K
BNY
147
Bank of New York Mellon
BNY
$107B
$28.7M 0.14%
398,932
+18,840
+5% +$1.24M
HPE icon
148
Hewlett Packard
HPE
$63.8B
$28.6M 0.14%
1,397,509
+12,657
+0.9% +$242K
BRK.A icon
149
Berkshire Hathaway Class A
BRK.A
$1.07T
$28.3M 0.14%
41
-3
-7% -$1.99M
MMM icon
150
3M
MMM
$91.9B
$28.3M 0.14%
206,876
-3,615
-2% -$443K

Similar funds

Glenmede Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenmede Trust held 1,443 positions worth $20.9B, up 6% from $19.7B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Glenmede Trust's Q3 2024 filing shows 92 new, 575 increased, 559 reduced and 58 closed positions. Its largest new stake was NOV: 859,708 shares worth $13.7M. The largest sale was Vertex Pharmaceuticals, an estimated $61.8M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q3 2024 buy was NOV: 859,708 shares worth $13.7M.
  • Glenmede Trust added most to Merck in Q3 2024, an estimated $49.3M increase.
  • Glenmede Trust's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $61.8M.
  • Glenmede Trust fully exited Pacira BioSciences in Q3 2024, selling an estimated $10.5M.
  • Glenmede Trust's ten largest holdings make up 24% of its $20.9B portfolio in Q3 2024.
  • Glenmede Trust opened 92 new positions and closed 58 in Q3 2024.
  • Glenmede Trust's portfolio value rose 6% quarter-over-quarter to $20.9B.

Based on Glenmede Trust's 13F filing for Q3 2024, filed 13 Nov 2024.